243 related articles for article (PubMed ID: 10640214)
21. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities.
Kaloutsi V; Fritsch RS; Buhr T; Restrepo-Specht I; Widjaja W; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):493-7. PubMed ID: 2058083
[TBL] [Abstract][Full Text] [Related]
22. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
23. [Cytogenetics and molecular studies confirm the histopathologic diagnosis of chronic myeloproliferative diseases].
Werner M; Nolte M; Ewing M; Kaloutsi V; Kausche F; Georgii A
Pathologe; 1995 Jan; 16(1):41-5. PubMed ID: 7886013
[TBL] [Abstract][Full Text] [Related]
24. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
25. Classification of myeloproliferative disorders by bone marrow histology.
Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
[No Abstract] [Full Text] [Related]
26. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders--analysis of planimetric and numeric characteristics by means of a knowledge based system.
Nafe R; Kaloutsi V; Fritsch RS; Georgii A
Exp Pathol; 1990; 40(4):213-9. PubMed ID: 2098268
[TBL] [Abstract][Full Text] [Related]
27. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
Georgii A; Vykoupil KF; Thiele J
Bibl Haematol; 1984; (50):41-56. PubMed ID: 6590038
[No Abstract] [Full Text] [Related]
28. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
29. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
30. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
31. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
33. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
Seewann HL
Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
[TBL] [Abstract][Full Text] [Related]
34. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders--a clue to diagnosis and classification.
Thiele J; Kvasnicka HM
Pathol Biol (Paris); 2001 Mar; 49(2):140-7. PubMed ID: 11317959
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
37. [Use of interferon in the treatment of chronic myeloproliferative disorders].
Robak T
Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
[TBL] [Abstract][Full Text] [Related]
38. [Myeloproliferative disorders].
Binder D; Fehr J
Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
[TBL] [Abstract][Full Text] [Related]
39. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
Thiele J; Holgado S; Choritz H; Georgii A
Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591
[TBL] [Abstract][Full Text] [Related]
40. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
